Literature DB >> 32835423

Escherichia coli, a common constituent of benign prostate hyperplasia-associated microbiota induces inflammation and DNA damage in prostate epithelial cells.

Sumeet Jain1,2, Ajit Gopal Samal3, Biswajit Das1,2, Biswaranjan Pradhan4, Nilanjan Sahu5, Debasish Mohapatra1,6, Prativa Kumari Behera7, Partha Sarathi Satpathi8, Akshaya K Mohanty9, Sanghamitra Satpathi7,10, Shantibhusan Senapati1.   

Abstract

BACKGROUND: The role of microbiota in the pathophysiology of benign prostate hyperplasia (BPH), especially in creating an inflammatory milieu may not be avoided. The major objectives of this study were to investigate the microbial composition of BPH tissues, its association with inflammation and check the effect of clinically isolated bacteria on prostate epithelial cells.
METHODS: The study includes 36 patients with a pathological diagnosis of BPH. Following strict aseptic measures, tissues were collected after transurethral resection of prostate, multiple pieces of the resected tissues were subjected to histopathological analysis, bacterial culture and genomic DNA extraction. Microbial composition was analyzed by culture and/or next-generation sequencing methods. Annotation of operational taxonomy unit has been done with an in-house algorithm. The extent of inflammation was scored through histological evaluation of tissue sections. The effect of clinical isolates on nuclear factor-κB (NF-κB) activity and induction of DNA-damage in the prostate epithelial cells were evaluated.
RESULTS: Histopathological analysis of the BPH tissues showed the presence of inflammation in almost all the tissues with a varied level at different regions of the same tissue section and the level of overall inflammation was different from patients to patients. Microbial culture of tissue samples showed the presence of live bacteria in 55.5% (20 out of 36) of the patient tissues. Majority of the isolates were coagulase-positive Staphylococcus, E. coli and Micrococcus spp. Further, V3 16S rRNA sequencing of the DNA isolated from BPH tissues showed the presence of multiple bacteria and the most common phylum in the BPH tissues were found to be Proteobacteria, Actinobacteria, Firmicutes, and Bacteroidetes. The E. coli, isolated from one of the tissue was able to activate NF-κB and induce DNA damage in prostate epithelial cells. Phospho-histone γH2A.X staining confirmed the presence of cells with damaged DNA lesion in BPH tissues and also correlated with the severity of inflammation.
CONCLUSION: Our study has shown that the BPH tissues do have a divergent microbial composition including the commonly found E. coli (phylum Proteobacteria), and these bacteria might contribute to the BPH-associated inflammation and/or tissue damage. The BPH-associated E. coli induced NF-κB signaling and DNA damage in prostate epithelial cells in vitro.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  BPH; DNA damage; NF-κB; inflammation; microbiota

Mesh:

Year:  2020        PMID: 32835423     DOI: 10.1002/pros.24063

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  9 in total

Review 1.  Multiple pathogens and prostate cancer.

Authors:  James S Lawson; Wendy K Glenn
Journal:  Infect Agent Cancer       Date:  2022-05-30       Impact factor: 3.698

2.  Alterations of gut microbiota diversity, composition and metabonomics in testosterone-induced benign prostatic hyperplasia rats.

Authors:  Lu-Yao Li; Jie Han; Lan Wu; Cheng Fang; Wei-Guang Li; Jia-Min Gu; Tong Deng; Chang-Jiang Qin; Jia-Yan Nie; Xian-Tao Zeng
Journal:  Mil Med Res       Date:  2022-03-28

3.  Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation.

Authors:  Petra Popovics; Asha Jain; Kegan O Skalitzky; Elise Schroeder; Hannah Ruetten; Mark Cadena; Kristen S Uchtmann; Chad M Vezina; William A Ricke
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

Review 4.  Prostate diseases and microbiome in the prostate, gut, and urine.

Authors:  Makito Miyake; Yoshihiro Tatsumi; Kenta Ohnishi; Tomomi Fujii; Yasushi Nakai; Nobumichi Tanaka; Kiyohide Fujimoto
Journal:  Prostate Int       Date:  2022-03-29

5.  Differential Microbial Signature Associated With Benign Prostatic Hyperplasia and Prostate Cancer.

Authors:  Purandar Sarkar; Samaresh Malik; Anwesha Banerjee; Chhanda Datta; Dilip Kumar Pal; Amlan Ghosh; Abhik Saha
Journal:  Front Cell Infect Microbiol       Date:  2022-07-05       Impact factor: 6.073

Review 6.  The Potential Role of Urinary Microbiome in Benign Prostate Hyperplasia/Lower Urinary Tract Symptoms.

Authors:  Seong Hyeon Yu; Seung Il Jung
Journal:  Diagnostics (Basel)       Date:  2022-08-01

7.  Phenolic Content and Antimicrobial and Anti-Inflammatory Effects of Solidago virga-aurea, Phyllanthus niruri, Epilobium angustifolium, Peumus boldus, and Ononis spinosa Extracts.

Authors:  Claudio Ferrante; Annalisa Chiavaroli; Paola Angelini; Roberto Venanzoni; Giancarlo Angeles Flores; Luigi Brunetti; Massimiliano Petrucci; Matteo Politi; Luigi Menghini; Sheila Leone; Lucia Recinella; Gokhan Zengin; Gunes Ak; Massimo Di Mascio; Francesco Bacchin; Giustino Orlando
Journal:  Antibiotics (Basel)       Date:  2020-11-06

Review 8.  Prostate Microbiota and Prostate Cancer: A New Trend in Treatment.

Authors:  Bangwei Che; Wenjun Zhang; Shenghan Xu; Jingju Yin; Jun He; Tao Huang; Wei Li; Ying Yu; Kaifa Tang
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244

Review 9.  Urobiome: An outlook on the metagenome of urological diseases.

Authors:  Rachel Shoemaker; Jayoung Kim
Journal:  Investig Clin Urol       Date:  2021-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.